Melanoma
From the Journals
Aspirin may accelerate cancer progression in older adults
From the Journals
Age, smoking among leading cancer risk factors for SLE patients
While older age was a risk factor for both breast and nonmelanoma skin cancers, use of antimalarial drugs lowered the risk of both.
From the Journals
COVID-19 impact: Less chemo, immune checkpoint inhibitors, and steroids
A survey finds the COVID-19 pandemic to have a significant impact on oncologists’ decision-making.
Clinical Insights
Artificial intelligence matches cancer genotypes to patient phenotypes
Conference Coverage
Study: Immune checkpoint inhibitors don’t increase risk of death in cancer patients with COVID-19
The mortality rate was 8% among patients who received immune checkpoint inhibitors, which is comparable with the overall mortality rate among...
From the Journals
Hepatitis screening now for all patients with cancer on therapy
All patients with cancer who are candidates for systemic therapy should be screened for hepatitis B, says the American Society of Clinical...
Feature
ASCO says ‘no’ to home infusions of cancer treatment, with exceptions
The American Society of Clinical Oncology has warned against intravenous infusion of chemotherapy and monoclonal antibodies in cancer patients’...
From the Journals
OK to treat many cancer patients despite pandemic, says ESMO
ESMO recommends against stopping or delaying cancer treatment that can impact survival.
News from the FDA/CDC
FDA approves triple drug combo for melanoma
Conference Coverage
Memphis clinic created to care for children and adolescents diagnosed with melanoma
To date, 20 female and 18 male patients have traveled to the clinic from 21 states and Puerto Rico for assessment and consultation.
Conference Coverage
CCC19, other registries help define COVID/cancer landscape
New data from CCC19 show an increased risk of death from COVID-19 among non-Hispanic black cancer patients and patients with hematologic...